149 related articles for article (PubMed ID: 27039073)
1. Quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo.
Li J; Tang C; Li L; Li R; Fan Y
J Exp Clin Cancer Res; 2016 Apr; 35():61. PubMed ID: 27039073
[TBL] [Abstract][Full Text] [Related]
2. Quercetin blocks t-AUCB-induced autophagy by Hsp27 and Atg7 inhibition in glioblastoma cells in vitro.
Li J; Tang C; Li L; Li R; Fan Y
J Neurooncol; 2016 Aug; 129(1):39-45. PubMed ID: 27174198
[TBL] [Abstract][Full Text] [Related]
3. γ-secretase inhibitor DAPT sensitizes t-AUCB-induced apoptosis of human glioblastoma cells in vitro via blocking the p38 MAPK/MAPKAPK2/Hsp27 pathway.
Li JY; Li RJ; Wang HD
Acta Pharmacol Sin; 2014 Jun; 35(6):825-31. PubMed ID: 24793313
[TBL] [Abstract][Full Text] [Related]
4. The apoptosis-resistance in t-AUCB-treated glioblastoma cells depends on activation of Hsp27.
Li J; Hu W; Lan Q
J Neurooncol; 2012 Nov; 110(2):187-94. PubMed ID: 22903412
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of AKT induced by phosphorylated Hsp27 confers the apoptosis-resistance in t-AUCB-treated glioblastoma cells in vitro.
Li R; Li J; Sang D; Lan Q
J Neurooncol; 2015 Jan; 121(1):83-9. PubMed ID: 25200832
[TBL] [Abstract][Full Text] [Related]
6. t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65.
Li J; Liu H; Xing B; Yu Y; Wang H; Chen G; Gu B; Zhang G; Wei D; Gu P; Li M; Hu W
J Neurooncol; 2012 Jul; 108(3):385-93. PubMed ID: 22382785
[TBL] [Abstract][Full Text] [Related]
7. Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27.
Sang DP; Li RJ; Lan Q
Acta Pharmacol Sin; 2014 Jun; 35(6):832-8. PubMed ID: 24902789
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction.
Gui Y; Li D; Chen J; Wang Y; Hu J; Liao C; Deng L; Xiang Q; Yang T; Du X; Zhang S; Xu D
Lipids Health Dis; 2018 May; 17(1):129. PubMed ID: 29843720
[TBL] [Abstract][Full Text] [Related]
9. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment.
Jakubowicz-Gil J; Langner E; Bądziul D; Wertel I; Rzeski W
Toxicol Appl Pharmacol; 2013 Dec; 273(3):580-9. PubMed ID: 24126416
[TBL] [Abstract][Full Text] [Related]
11. Rosmarinic acid and siRNA combined therapy represses Hsp27 (HSPB1) expression and induces apoptosis in human glioma cells.
Şengelen A; Önay-Uçar E
Cell Stress Chaperones; 2018 Sep; 23(5):885-896. PubMed ID: 29627902
[TBL] [Abstract][Full Text] [Related]
12. The effect of quercetin and imperatorin on programmed cell death induction in T98G cells in vitro.
Bądziul D; Jakubowicz-Gil J; Langner E; Rzeski W; Głowniak K; Gawron A
Pharmacol Rep; 2014 Apr; 66(2):292-300. PubMed ID: 24911084
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation.
Liu JY; Tsai HJ; Hwang SH; Jones PD; Morisseau C; Hammock BD
Br J Pharmacol; 2009 Jan; 156(2):284-96. PubMed ID: 19154430
[TBL] [Abstract][Full Text] [Related]
14. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.
Xu DY; Davis BB; Wang ZH; Zhao SP; Wasti B; Liu ZL; Li N; Morisseau C; Chiamvimonvat N; Hammock BD
Int J Cardiol; 2013 Aug; 167(4):1298-304. PubMed ID: 22525341
[TBL] [Abstract][Full Text] [Related]
15. Suppression of HSP27 increases the anti‑tumor effects of quercetin in human leukemia U937 cells.
Chen X; Dong XS; Gao HY; Jiang YF; Jin YL; Chang YY; Chen LY; Wang JH
Mol Med Rep; 2016 Jan; 13(1):689-96. PubMed ID: 26648539
[TBL] [Abstract][Full Text] [Related]
16. Effects of quercetin on proliferation and migration of human glioblastoma U251 cells.
Liu Y; Tang ZG; Lin Y; Qu XG; Lv W; Wang GB; Li CL
Biomed Pharmacother; 2017 Aug; 92():33-38. PubMed ID: 28528183
[TBL] [Abstract][Full Text] [Related]
17. 6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.
Du S; Sarver JG; Trabbic CJ; Erhardt PW; Schroering A; Maltese WA
Cancer Chemother Pharmacol; 2019 Feb; 83(2):237-254. PubMed ID: 30426158
[TBL] [Abstract][Full Text] [Related]
18. A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro.
Shen L; Peng H; Zhao S; Xu D
Biol Chem; 2014 Apr; 395(4):443-51. PubMed ID: 24225128
[TBL] [Abstract][Full Text] [Related]
19. TGX-221 inhibits proliferation and induces apoptosis in human glioblastoma cells.
Yang X; Yang JA; Liu BH; Liao JM; Yuan FE; Tan YQ; Chen QX
Oncol Rep; 2017 Nov; 38(5):2836-2842. PubMed ID: 29048665
[TBL] [Abstract][Full Text] [Related]
20. miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.
Chen L; Wang X; Wang H; Li Y; Yan W; Han L; Zhang K; Zhang J; Wang Y; Feng Y; Pu P; Jiang T; Kang C; Jiang C
Eur J Cancer; 2012 Nov; 48(16):3104-11. PubMed ID: 22406049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
